Though antineoplastic drugs have demonstrated benefits as a cancer treatment, they pose significant occupational health risks to clinicians administering the drugs. The Centers for Disease Control and ...

PharmaResearch Co., Ltd. (CEO: Jihoon Sohn) today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for PRD-101, enabling the ...

An emerging class of anticancer drugs called EZH2 inhibitors may greatly enhance the potency of some cancer immunotherapies, according to a preclinical study led by Weill Cornell Medicine lymphoma ...

Association Between Prescription Co-Payment Amount and Compliance With Adjuvant Hormonal Therapy in Women With Early-Stage Breast Cancer Randomized clinical trials (RCTs) that evaluated approved new ...

In a recent study published in the journal Scientific Reports, researchers leveraged the knowledge that cancers and specific types of dementia share pathophysiological underpinnings to investigate the ...

Toward Better End-of-Life Care: Strategies to Reduce Hospital Utilization and Improve Quality in Metastatic Cancer ASCO Guidelines provide recommendations with comprehensive review and analyses of the ...

CHICAGO, IL / ACCESS Newswire / January 22, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in ...

A new study shows how an anticancer drug triggers an "outside in" signal that gets it sucked into a cancer cell. The work, published Jan. 29 in Nature Communications, reveals a new signaling mechanism ...

The latest map of all the genes involved in a set of tumor cells exposes which mutations drive cancer and how to possibly treat them. The Human Genome Project provided the first glimpse of the power ...